Shravan Subramanyam to Lead Claypond Capital's Visionary Med-Tech Platform

Claypond Capital, the family investment office of Dr. Ranjan Pai, has announced the appointment of Shravan Subramanyam to lead its groundbreaking medical technology platform. This strategic initiative aims to revolutionize the med-tech sector through the development of innovative medical equipment and digital healthcare solutions, focusing on localized production and catering to both domestic and global healthcare needs.

With over two decades of leadership experience in life sciences and medical devices, Dr. Subramanyam brings an unparalleled depth of expertise to this transformative endeavor. A distinguished physician with a degree from Madras Medical College (MMC) and a Master’s in Healthcare Administration from Cornell University, he has held pivotal roles at renowned organizations, including Roche, Novartis, and Wipro GE Healthcare.

Dr. Subramanyam is also recognized for his significant contributions to healthcare policy and med-tech advancement during his tenure as President of NatHealth. His active involvement with industry bodies such as FICCI and CII has helped shape impactful healthcare initiatives, fostering innovation and improving accessibility.

Claypond Capital’s medical technology platform is poised to position India as a global leader in med-tech innovation. By leveraging cutting-edge technologies and addressing critical healthcare challenges, the initiative aims to deliver accessible, affordable, and transformative solutions for South Asia and beyond.

“Dr. Subramanyam’s appointment aligns perfectly with our vision to advance healthcare through innovation,” said Dr. Ranjan Pai, Founder of Claypond Capital. “His leadership and expertise will drive the platform’s mission to meet the evolving needs of patients and healthcare providers on a global scale.”

" I’m happy to share that I’m starting a new fulltime position as Medical Technology Platform Head at Claypond Capital! After an enriching stint at Premji Invest where I had the opportunity to learn a new operating skill from some of the best in the business, I am excited to take my career forward with Claypond, where I will work closely with the investment team and investee companies in the medical equipment space said, Dr. Subramanyam "

This appointment underscores Claypond Capital’s commitment to redefining healthcare delivery and empowering the med-tech industry with a future-ready approach.